Estrogen receptor (ER) and epidermal growth factor receptor (EGFR) as targets for dual lung cancer therapy: not just a case?

J Thorac Oncol. 2008 Jun;3(6):684-5. doi: 10.1097/JTO.0b013e3181757aec.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / secondary
  • Antineoplastic Agents / therapeutic use
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • ErbB Receptors / antagonists & inhibitors*
  • Female
  • Follow-Up Studies
  • Gefitinib
  • Humans
  • Letrozole
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Nitriles / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / therapeutic use*
  • Receptors, Estrogen / antagonists & inhibitors*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / secondary
  • Triazoles / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitriles
  • Protein Kinase Inhibitors
  • Quinazolines
  • Receptors, Estrogen
  • Triazoles
  • Letrozole
  • ErbB Receptors
  • Gefitinib